SCHEMBL29601739

SCHEMBL29601739

CCOc1ccc(-c2csc(N)n2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
NPC1 O15118 9/20 0.47
RAB9A P51151 8/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
POLB P06746 1/20 0.47
LTA4H P09960 3/20 0.44
HSD17B10 Q99714 3/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 2/20 0.43
CYP3A4 P08684 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CDC25A P30304 1/20 0.41
CDC25B P30305 1/20 0.41
CDC25C P30307 1/20 0.41
DUSP3 P51452 1/20 0.41
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24358021 1.00 MEN1 (0.52) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL21484651 0.84 NPC1 (0.63) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL31692110 0.81 NQO1 (0.59) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7403707 0.81 RAB9A (0.68) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL24358019 0.81 LTA4H (0.42) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL3038954 0.78 NPC1 (0.67) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL30745716 0.77 GAA (0.53) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL24357980 0.77 GAA (0.53) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL18006558 0.75 CCR1 (0.59) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL24358193 0.75 MEN1 (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 CN disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed